This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.
Also known as: Pralmorelin
GHRP-2 is a synthetic hexapeptide growth hormone-releasing peptide that potently stimulates GH release from the pituitary gland. It produces significantly higher GH pulses than ipamorelin but also raises cortisol and prolactin levels.
GHRP-2 binds both the GHS-R1a receptor (pituitary) and a secondary receptor, producing strong pulsatile GH release. Unlike ipamorelin, GHRP-2 does not require concurrent GHRH stimulation for robust GH output, though the combination is additive. Cortisol and ACTH elevation occurs through central hypothalamic mechanisms — a key difference from more selective GHRPs. Prolactin elevation is moderate and typically dose-dependent.
GHRP-2 binds both the GHS-R1a receptor (pituitary) and a secondary receptor, producing strong pulsatile GH release. Unlike ipamorelin, GHRP-2 does not require concurrent GHRH stimulation for robust GH output, though the combination is additive. Cortisol and ACTH elevation occurs through central hypothalamic mechanisms — a key difference from more selective GHRPs. Prolactin elevation is moderate and typically dose-dependent.
GHRP-2 is a synthetic hexapeptide growth hormone-releasing peptide that potently stimulates GH release from the pituitary gland. It produces significantly higher GH pulses than ipamorelin but also raises cortisol and prolactin levels. Phase 2 trials have evaluated GHRP-2 for short stature, GH deficiency, and cachexia. Favored by researchers seeking maximum GH output.
IUPAC Name
H-Ala-D-βNal-Ala-Trp-D-Phe-Lys-NH2
CAS Number
158861-67-7
Molecular Formula
C45H55N9O6
Molecular Mass
817.99 g/mol
Create a free account to:
Join 2,800+ researchers
Create a free account to:
Join 2,800+ researchers
Create a free account to:
Join 2,800+ researchers
$29.99
$2.9990
1
1
vial
Growth Hormone / IGF-1 Axis
CJC-1295 without DAC (Modified GRF 1-29) is a synthetic 29-amino acid GHRH analog with four amino acid substitutions that extend its half-life from under 2 minutes to approximately 30 minutes.
Growth Hormone / IGF-1 Axis
CJC-1295 with DAC uses a Drug Affinity Complex linker (maleimidopropionic acid) that forms a permanent covalent bond with serum albumin after injection, extending the half-life to 6–8 days.
Growth Hormone / IGF-1 Axis
GHRP-6 is a synthetic hexapeptide growth hormone secretagogue and one of the original GHRPs studied.
Growth Hormone / IGF-1 Axis
Hexarelin is a synthetic hexapeptide growth hormone secretagogue that produces the most potent GH release of any GHRP.
Growth Hormone / IGF-1 Axis
IGF-1 LR3 (Long R3 IGF-1) is a modified analog of insulin-like growth factor 1 featuring an arginine substitution at position 3 and a 13-amino acid N-terminal extension.
Growth Hormone / IGF-1 Axis
Ipamorelin is a selective pentapeptide growth hormone secretagogue that mimics ghrelin at the GHSR-1a receptor with high selectivity.
GHRP-2 is a synthetic hexapeptide growth hormone-releasing peptide that potently stimulates GH release from the pituitary gland. It produces significantly higher GH pulses than ipamorelin but also raises cortisol and prolactin levels. Phase 2 trials have evaluated GHRP-2 for short stature, GH deficiency, and cachexia. Favored by researchers seeking maximum GH output.
GHRP-2 is available in vial form.
Prices start at $29.99 across 1 verified vendor.
Compare prices, payment methods, shipping, and COA scores across 1 vendor.
212 PubMed studies
Data Completeness
88%Research Credibility
Well-researched compound
Half-Life
~1 hour
Molecular Weight
817.99 g/mol
Administration
Subcutaneous, Intramuscular, Intranasal
CAS Number
158861-67-7
Trial Phase
Phase 2
Common Side Effects
Stop Use If
Research Disclaimer
This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.